These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21960602)

  • 21. The polypill in the primary prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Fundam Clin Pharmacol; 2010 Feb; 24(1):29-35. PubMed ID: 20002198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
    Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development.
    Hilbrich L; Truelsen T; Yusuf S
    Int J Stroke; 2007 May; 2(2):104-8. PubMed ID: 18705961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular disease and global health: threat and opportunity.
    Greenberg H; Raymond SU; Leeder SR
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W-5-31-W-5-41. PubMed ID: 15671084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin for the primary prevention of vascular events?
    Morgan G
    Public Health; 2009 Dec; 123(12):787-8. PubMed ID: 19914670
    [No Abstract]   [Full Text] [Related]  

  • 27. A look at the polypill story 10 years later.
    Wilkinson E
    Eur Heart J; 2013 Jul; 34(27):2019-20. PubMed ID: 23853173
    [No Abstract]   [Full Text] [Related]  

  • 28. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Polypill: From Promise to Pragmatism.
    Huffman MD
    PLoS Med; 2015 Aug; 12(8):e1001862. PubMed ID: 26263422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
    Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
    Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global cardiovascular disease prevention: a call to action for nursing: community-based and public health prevention initiatives.
    Fletcher BJ; Himmelfarb CD; Lira MT; Meininger JC; Pradhan SR; Sikkema J
    J Cardiovasc Nurs; 2011; 26(4 Suppl):S35-45. PubMed ID: 21659811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 33. Time to implement the polypill approach.
    Holt S
    N Z Med J; 2009 Jun; 122(1296):88-9. PubMed ID: 19652688
    [No Abstract]   [Full Text] [Related]  

  • 34. What happened to the polypill?
    Watts G
    BMJ; 2008 Sep; 337():a1822. PubMed ID: 18819953
    [No Abstract]   [Full Text] [Related]  

  • 35. "Polypill" to fight cardiovascular disease: birthday present was much appreciated.
    Ramos F
    BMJ; 2003 Oct; 327(7418):808; discussion 809; author reply 809-10. PubMed ID: 14525892
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular Disease Prevention at a Crossroads:: Precision Medicine or Polypill?
    Joyner MJ; Paneth N
    JAMA; 2019 Dec; 322(23):2281-2282. PubMed ID: 31764938
    [No Abstract]   [Full Text] [Related]  

  • 37. Polypill holds promise for people with chronic disease.
    Wise J
    Bull World Health Organ; 2005 Dec; 83(12):885-7. PubMed ID: 16462975
    [No Abstract]   [Full Text] [Related]  

  • 38. "Polypill" to fight cardiovascular disease: interpretation of trial data is optimistic.
    Assmann G; Cullen P; Schulte H
    BMJ; 2003 Oct; 327(7418):808; discussion 809; author reply 809-10. PubMed ID: 14525891
    [No Abstract]   [Full Text] [Related]  

  • 39. Why is there more heat than light concerning the polypill?
    Rodgers A; Patel A
    BMJ; 2008 Oct; 337():a2162. PubMed ID: 18936069
    [No Abstract]   [Full Text] [Related]  

  • 40. Uses of polypills for cardiovascular disease and evidence to date.
    Huffman MD; Xavier D; Perel P
    Lancet; 2017 Mar; 389(10073):1055-1065. PubMed ID: 28290995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.